Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment

Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years.

Detalles Bibliográficos
Autores principales: Kim, Eun Sun, Jeen, Yoon Tae, Keum, Bora, Seo, Yeon Seok, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck, Ryu, Ho Sang
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852720/
https://www.ncbi.nlm.nih.gov/pubmed/20431770
http://dx.doi.org/10.5009/gnl.2009.3.4.325
_version_ 1782179969341849600
author Kim, Eun Sun
Jeen, Yoon Tae
Keum, Bora
Seo, Yeon Seok
Chun, Hoon Jai
Um, Soon Ho
Kim, Chang Duck
Ryu, Ho Sang
author_facet Kim, Eun Sun
Jeen, Yoon Tae
Keum, Bora
Seo, Yeon Seok
Chun, Hoon Jai
Um, Soon Ho
Kim, Chang Duck
Ryu, Ho Sang
author_sort Kim, Eun Sun
collection PubMed
description Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years.
format Text
id pubmed-2852720
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases
record_format MEDLINE/PubMed
spelling pubmed-28527202010-04-29 Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment Kim, Eun Sun Jeen, Yoon Tae Keum, Bora Seo, Yeon Seok Chun, Hoon Jai Um, Soon Ho Kim, Chang Duck Ryu, Ho Sang Gut Liver Case Report Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years. The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2009-12 2009-12-31 /pmc/articles/PMC2852720/ /pubmed/20431770 http://dx.doi.org/10.5009/gnl.2009.3.4.325 Text en Copyright © 2009 The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases
spellingShingle Case Report
Kim, Eun Sun
Jeen, Yoon Tae
Keum, Bora
Seo, Yeon Seok
Chun, Hoon Jai
Um, Soon Ho
Kim, Chang Duck
Ryu, Ho Sang
Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title_full Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title_fullStr Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title_full_unstemmed Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title_short Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
title_sort remission of cap polyposis maintained for more than three years after infliximab treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852720/
https://www.ncbi.nlm.nih.gov/pubmed/20431770
http://dx.doi.org/10.5009/gnl.2009.3.4.325
work_keys_str_mv AT kimeunsun remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT jeenyoontae remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT keumbora remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT seoyeonseok remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT chunhoonjai remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT umsoonho remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT kimchangduck remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment
AT ryuhosang remissionofcappolyposismaintainedformorethanthreeyearsafterinfliximabtreatment

Ejemplares similares